Bedside Snapshot
- Normal (Adult)
- 4.5–11.0 ×10³/µL (4.5–11.0 ×10⁹/L). Typical; lab-specific. Infant and child ranges are higher.
- Critical Values
- <2.0 or >30 ×10³/µL (typical; lab-specific). WBC above 100 with neurologic or lung signs is a leukostasis emergency.
- High Suggests
- Bacterial infection (bands, fever)
- Steroids, stress, exercise, labor
- Viral infection (lymphocytosis)
- Leukemia (blasts)
- Low Suggests
- Chemotherapy or marrow failure
- Clozapine, antithyroid drugs, sulfonamides
- Severe sepsis (consumption)
- HIV or viral infection
- Act Now If
- Fever with ANC below 0.5 ×10³/µL: urgent empiric antibiotics per protocol. WBC above 100 with neuro or lung signs: leukostasis; call hematology.
- Watch Out For
- A normal or high count does not rule out infection, and a steroid dose can raise WBC without infection. Read the differential and the patient.
Reference & Critical Ranges
Lab-specific ranges: Every lab sets its own interval, based on its analyzer and the population it serves. Your lab report wins. The values below are typical only.
Reference ranges
| Population | Conventional (×10³/µL) | SI (×10⁹/L) | Notes |
|---|---|---|---|
| Adult | 4.5–11.0 | 4.5–11.0 | Typical adult interval |
| Pregnancy | Rises; no fixed interval | Rises; no fixed interval | Higher in the third trimester and during labor; interpret against the trend |
| Neonate (0–28 days) | 9.0–30.0 | 9.0–30.0 | Highest counts of life; secondary-source band, verify with lab |
| Infant (1 month–under 2 years) | 5.0–17.0 | 5.0–17.0 | Counts fall over the first months |
| Child (2–10 years) | 5.0–13.5 | 5.0–13.5 | Infection-related rises are common |
| Adolescent (11–18 years) | 4.5–13.0 | 4.5–13.0 | Close to the adult interval |
Severity & critical values
| Level | Conventional (×10³/µL) | SI (×10⁹/L) | What it means |
|---|---|---|---|
| Critical (low) | <2.0 | <2.0 | Severe leukopenia; high infection risk; check ANC and call the lab for a smear |
| Leukopenia | 2.0–4.4 | 2.0–4.4 | Find the cause: drugs, marrow, viral, nutritional |
| Normal | 4.5–11.0 | 4.5–11.0 | No WBC-based action |
| Mild leukocytosis | >11.0–15.0 | >11.0–15.0 | Common with infection, stress, steroids and smoking |
| Moderate leukocytosis | >15.0–30.0 | >15.0–30.0 | Usually reactive; read the differential |
| Critical (high) | >30.0 | >30.0 | Severe infection, leukemoid reaction or leukemia until proven otherwise |
| Hyperleukocytosis | >100 | >100 | Leukostasis risk, mainly in acute leukemia |
Critical values: WBC <2.0 or >30 ×10³/µL, typical and lab-specific. Above 100 ×10³/µL with neurologic or respiratory symptoms, that is a leukostasis emergency.
Conversion: Divide cells/µL by 1,000 and you get ×10³/µL, which is the same figure as ×10⁹/L. Take 4,500 cells/µL. That is 4.5 ×10⁹/L.
Absolute neutrophil count (ANC)
ANC = WBC × (% neutrophils + % bands) ÷ 100
Neutropenia starts when the ANC falls below 1.5 ×10³/µL. Fall below 0.5 ×10³/µL and it is severe.
Causes of Abnormal Results
High (leukocytosis >11.0 ×10³/µL)
| Mechanism | Common causes | Bedside clue |
|---|---|---|
| Bacterial infection or sepsis | Pneumonia, urinary, intra-abdominal, skin and soft-tissue infection | Fever, tachycardia, left shift (bands) |
| Stress and demargination | Corticosteroids, epinephrine, seizure, exercise, surgery, trauma, labor | Neutrophilia that falls once the trigger ends |
| Infectious lymphocytosis | EBV, CMV, pertussis (bacterial) | Atypical lymphocytes on the smear (EBV, CMV) |
| Drugs | Corticosteroids, lithium, G-CSF or GM-CSF | Check the medication list before attributing the count to disease |
| Tissue injury | Myocardial infarction, burns, pancreatitis | Leukocytosis alongside the primary injury |
| Leukemoid reaction | Severe infection, hemorrhage, hemolysis | Immature myeloid cells without blasts; non-malignant |
| Acute leukemia | Acute myeloid or lymphoblastic leukemia | Blasts on the differential; anemia or thrombocytopenia |
| Chronic leukemia | Chronic myeloid leukemia; chronic lymphocytic leukemia | Persistent count with a left shift (CML) or mature lymphocytes (CLL) |
Leukostasis: In acute leukemia, a count above 100 ×10³/µL can sludge the microcirculation. Watch for headache, confusion, vision change, stroke, dyspnea or hypoxia. Those are the warning signs, and this is time-critical (see Management Priorities). Symptoms can appear at lower counts, especially in monocytic AML. Treat the symptoms, not just the number. Suspected acute promyelocytic leukemia (bleeding, DIC) is an emergency too.
Low (leukopenia <4.5 ×10³/µL)
| Mechanism | Common causes | Bedside clue |
|---|---|---|
| Marrow suppression | Chemotherapy, radiation, aplastic anemia, myelodysplastic syndromes | Chemotherapy nadir about 1–2 weeks after treatment |
| Drugs | Clozapine (boxed warning for severe neutropenia), antithyroid drugs, carbamazepine, sulfonamides, prolonged beta-lactam courses | Timing of the drug relative to the count |
| Overwhelming sepsis | Consumption of white cells exceeds production | Low count with fever or hypotension is not reassuring |
| Viral infection | HIV, hepatitis, EBV, CMV | Lymphopenia pattern; HIV testing when unexplained |
| Nutritional | Vitamin B12, folate, copper deficiency | Macrocytosis, neurologic signs, anemia |
| Hypersplenism or autoimmune | Enlarged spleen; systemic lupus erythematosus | Splenomegaly; autoimmune features |
| Benign variant | Duffy-null associated neutrophil count (formerly benign ethnic neutropenia) | Low neutrophils, normal health, no infection history; a normal variant |
Interpretation & Bedside Approach
Step-by-step approach
- Is it real? Check for a clotted, delayed or mis-labeled specimen and repeat if the result does not fit the patient.
- How sick is the patient? Vital signs, mental status, perfusion and temperature matter more than the count.
- Acute or chronic, and what is the trend? A single value is less useful than the last two or three counts.
- Calculate the ANC. Use the formula in Reference & Critical Ranges. Neutropenia changes the infection plan.
- Read the differential and smear. The cell type points to the cause. Blasts or a persistent mature lymphocytosis need hematology input.
- Escalate or disposition. Treat fever with a low ANC as an emergency; treat symptomatic hyperleukocytosis as time-critical.
Decision patterns
| Pattern | Suggests |
|---|---|
| Neutrophilia with bands and fever | Acute bacterial infection or inflammation |
| Neutrophilia without fever, after steroids or stress | Demargination; repeat once the trigger has ended |
| Persistent mature lymphocytosis | Chronic lymphocytic leukemia until flow cytometry says otherwise |
| Lymphocytosis with atypical lymphocytes | Viral infection (EBV, CMV) |
| Blasts on the differential | Acute leukemia until proven otherwise |
| Low ANC with fever | Febrile neutropenia: an emergency |
Sepsis is not defined by WBC: The Sepsis-3 definitions (2016) dropped SIRS. SIRS counted a WBC above 12,000 or below 4,000 cells/µL as one of its criteria. Sepsis now means organ dysfunction, a SOFA change of 2 or more. qSOFA is a bedside prompt, and it is not a reliable screen. Use a validated tool such as NEWS or MEWS, with clinical judgment, per local protocol, and not the WBC alone. SSC 2021 suggests against qSOFA as a single screening tool compared with SIRS, NEWS or MEWS.
Management Priorities
Emergency: Febrile neutropenia (ANC below 0.5 ×10³/µL with fever)
- Treat as an emergency: Fever of 38.3 °C (101 °F) once, or 38.0 °C (100.4 °F) sustained over 1 hour, with an ANC below 0.5 ×10³/µL or expected to fall below it within 48 hours.
- Antibiotics: Start empiric broad-spectrum antipseudomonal therapy per local protocol. The ASCO/IDSA 2018 update sets a target within 1 hour of triage; IDSA 2010: urgently, within 2 hours of presentation. Do not delay antibiotics for cultures or the ANC.
- Cultures: Draw blood cultures only if this does not delay the first dose.
- Monitor and escalate: Notify the receiving team and oncology. Screen for sepsis, reassess vital signs and repeat the CBC with differential as ordered.
Emergency: Symptomatic hyperleukocytosis (WBC above 100 ×10³/µL with neurologic or lung signs)
- Recognize: Headache, confusion, visual change, stroke, dyspnea or hypoxia in a patient with a very high count.
- Call hematology now: Cytoreduction by leukapheresis, hydroxyurea, or both, per hematology. Delay in starting chemotherapy is the main preventable harm.
- Avoid RBC transfusion unless clearly needed; transfusion raises blood viscosity. Hematology to advise.
- Suspected acute promyelocytic leukemia: bleeding or DIC needs coagulation tests and urgent hematology input.
- Monitor for tumor lysis: Check electrolytes, uric acid, creatinine and calcium during cytoreduction.
- Route to a capable center: Transfer to a unit that can perform apheresis and intensive care.
Medications
This page does not list drug doses. Empiric antibiotic agents, doses and cytoreduction are set by the receiving oncology or hematology team and local protocol.
Definitive care & disposition
- Oncology or hematology consult: For an ANC below 0.5 ×10³/µL, any blasts, or a persistent unexplained lymphocytosis.
- ICU criteria: Sepsis or shock with neutropenia, or leukostasis with neurologic or respiratory compromise.
- Follow-up: Trend the CBC with differential; one value rarely settles the question.
Doses are typical references. Follow local protocols, medical direction and institutional policy.
Field & Transport Considerations
Point-of-care testing
Field crews don't measure WBC. Vital signs, mental status, temperature and glucose tell you who needs a lab CBC and a fast infection plan. Some services carry a point-of-care CBC analyzer. Check what yours stocks and where its limits are.
Before and during interfacility transport
- Obtain: The most recent WBC and ANC with the date, chemotherapy regimen and last dose, and any known neutropenia.
- Treat the fever: Assume a febrile patient on chemotherapy is neutropenic until labs say otherwise. Run the febrile neutropenia steps above and notify the receiving team.
- Do not hold transport: Do not delay transfer to wait for a repeat WBC.
- Infection precautions: Keep the patient away from visibly ill contacts and minimize invasive procedures during transport.
- Neutropenic precautions: No rectal temperatures, suppositories, enemas or rectal medications. Older and steroid-treated patients may not run a fever. Treat hypotension or altered mental status as possible sepsis anyway.
Special Populations
| Population | What changes | Clinical implication |
|---|---|---|
| Neonates and infants | Higher normal counts at birth that fall over the first months | Use the age band; a neonatal count of 25 ×10³/µL may be normal |
| Children and adolescents | Age-specific ranges; viral infections are a common cause of lymphocytosis | Compare against the age band before calling leukocytosis or leukopenia. A child with cancer and fever follows pediatric oncology febrile neutropenia protocols. |
| Pregnancy | Counts rise through pregnancy, during labor and early postpartum | Do not dismiss a high count in labor; an infection work-up still applies |
| Older adults | Adult range applies; infection can produce a blunted response | A modest or low count with a change in mental status still needs a sepsis screen |
| Benign variant (DANC) | Lower neutrophil counts without higher infection risk in most patients | A normal variant; avoid treatment or repeated workup for an isolated low ANC |
Interfering Factors & Pitfalls
Collection and handling
| Factor | Effect | Why | Avoid or fix |
|---|---|---|---|
| Clotted specimen | False low | Cells are trapped in the clot | Redraw into a lavender-top tube and mix well |
| Delayed processing | Altered counts | Cells change with time and storage temperature | Process within the lab's stated stability window |
| nRBCs or platelet clumps | False + | Some analyzers count nucleated RBCs or clumped platelets as leukocytes | Request a smear review and a corrected WBC |
Medications and physiology
| Factor | Effect | Why | Avoid or fix |
|---|---|---|---|
| Corticosteroids, epinephrine | ↑ | Demargination from vessel walls | Note the dose and timing before reading the count |
| G-CSF, GM-CSF, lithium | ↑ | Marrow stimulation or chronic effect | Compare with the medication history |
| Clozapine, antithyroid drugs | ↓ | Drug-induced neutropenia | Check the ANC, not only the WBC |
| Smoking, exercise, seizure, labor | ↑ | Stress and demargination, often transient | Repeat after the trigger resolves |
Common misinterpretations
- A normal total count excludes infection: It doesn't. Read the differential, the ANC and the patient.
- A steroid-related rise means infection: Steroids raise the count on their own. No infection needed.
- A high count means leukemia: Most leukocytosis is reactive. Blasts are the signal. So is a count that stays high with no explanation.
Low count is not reassurance: A low count feels safe. It isn't. Severe sepsis can use up white cells, so a low WBC with fever or hypotension gets the same urgency as a high one.
Physiology & Test Basics
What it measures
The WBC is the total number of leukocytes per microliter of blood. It screens for infection, inflammation, marrow disease and leukemia. This page covers the total. The differential splits that total into neutrophils, lymphocytes, monocytes, eosinophils and basophils.
Physiology & regulation
- Production: The bone marrow makes leukocytes.
- Neutrophils: First on scene in acute bacterial infection.
- Lymphocytes: They run adaptive immunity. In many viral infections, they are the main cell.
- Demargination: Epinephrine and corticosteroids pull neutrophils off the vessel walls and into circulation. The count climbs with no new cells made.
How it is measured
It runs on whole blood drawn into a lavender-top (EDTA) tube. Mix the tube well, then run it on an automated analyzer. Results come back in ×10³/µL. Each lab sets its own specimen stability, so follow its limit for time and temperature.
Why it matters
The WBC is where you start with infection and marrow failure. Too high or too low, the count sends you to the differential, the ANC and the patient before any treatment decision.
Clinical Pearls
The WBC is half the story: Read the differential every time. A count of 15 ×10³/µL with 90% neutrophils points toward bacterial infection. Same total, 80% lymphocytes? Think virus or chronic lymphocytic leukemia.
Left shift: Rising bands with fever points to acute bacterial infection or severe inflammation. Immature myeloid cells past the bands are a different story. You need the smear and the clinical picture to tell a leukemoid reaction from leukemia.
Steroid effect: Steroids push neutrophils up within hours of a dose. That rise is not infection on its own. Pull the medication history before you treat anything.
Transport pearl: Fever on chemotherapy means neutropenic until labs prove otherwise. Tell the receiving team early, so the transfer doesn't hold up antibiotics.
Monitoring pearl: One value tells you little. Follow the trend. On chemotherapy, the nadir matters, and fever, hypotension and altered mental status are what to watch for.
Leukemoid reaction vs leukemia: A leukemoid reaction has a non-malignant trigger, and it clears when that trigger is treated. Blasts, cytopenias or counts that stay unexplained push you toward leukemia.
Benign variant is not a reason to delay: Known benign variant, low ANC, healthy patient? That is a lab finding. Fever in any neutropenic patient still starts the febrile neutropenia pathway.
References
- Freifeld AG, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2011;52(4):e56–e93. https://doi.org/10.1093/cid/cir073
- Taplitz RA, et al. Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol. 2018;36(14). https://doi.org/10.1200/JCO.2017.77.6211
- Singer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801–810. https://pubmed.ncbi.nlm.nih.gov/26903338/
- Hallek M, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of chronic lymphocytic leukemia. Blood. 2018;131(25):2745–2760. https://doi.org/10.1182/blood-2017-09-806398
- Evans L, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Crit Care Med. 2021;49(11):e1063–e1143. https://pubmed.ncbi.nlm.nih.gov/34605781/
- Riley LK, Rupert J. Evaluation of patients with leukocytosis. Am Fam Physician. 2015;92(11):1004–1011. https://www.aafp.org/pubs/afp/issues/2015/1201/p1004.html
Medical Disclaimer
- For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
- Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
- Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
AI was used to assist in organizing, paraphrasing, and formatting this information.